No differences in phospholipase-A2 activity between acute psychiatric patients and controls

Schizophrenia Research

Volumn 26, Issue 2-3, 1997, Pages 103-105

  Katila, Heikki ^a   Appelberg, Björn ^a   Rimón, Ranan ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Acute psychiatric disorders; Phospholipase A2 activity

Indexed keywords

PHOSPHOLIPASE A2; PHOSPHOLIPASE A;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FLUOROMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PRIORITY JOURNAL; SCHIZOPHRENIA; ACUTE DISEASE; COMPARATIVE STUDY; ENZYMOLOGY; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE;

ACUTE DISEASE; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPASES A; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 0030608885     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(97)00054-6     Document Type: Article

References (9)

1. cited in text but not in bib list.
2. 2 activity in Epstein-Barr virus-transformed lymphoblast cells from schizophrenic patients. Biol. Psychiatry. 29:1991;1058-1062.
3. 2 activity in schizophrenia: a replication study. Biol. Psychiatry. 28:1990;495-501.
4. 2 activity in schizophrenic patients: reduction after neuroleptic therapy. Biol. Psychiatry. 22:1987;421-426.
5. Gattaz W.F., Steudle A., Maras A., Brunner J. Accelerated breakdown of platelet membrane phospholipids in schizophrenia. Schizophr. Res. 11:1994;122.
6. 2 activity in schizophrenics and other psychiatric patients. Biol. Psychiatry. 34:1993;641-649.
7. 31P nuclear magnetic resonance spectroscopy: Neurodevelopment and schizophrenia. Schizophr. Bull. 19:1993;35-53.
8. 31P-MR spectroscopy study. Schizophr. Res. 13:1994;209-215.
9. 2 in serum. Clin. Chem. 31:1985;714-717.